Emergent BioSolutions EBS
NYSE EBS
$6.09 -0.01 (-0.16%)
As of: Nov 10, 2026 · 12:31 PM EST

Emergent BioSolutions (EBS) Acquisitions (2013 - 2020)

Updated

Emergent BioSolutions (EBS) reported Acquisitions of -$10 million for Q4 2020, compared with -$10 million a year earlier.

Analysis

Emergent BioSolutions (EBS) Acquisitions (2013 - 2020) Analysis & Trends

Over the twelve months ended Dec 31, 2020, Emergent BioSolutions' Acquisitions came in at -$20 million; for FY2018, it was $827.7 million, up 604.4% from FY2017.

  • Acquisitions has a five-year compound annual growth rate of 100.0% (FY2013 to FY2018).
  • By year, Acquisitions came in at $117.5 million in FY2017, $650,000 in FY2015 (-99.6%) and $179.38 million in FY2014 (+593.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -17.15 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 10.59 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -10.00 Mn
Dec 31, 2019 -10.00 Mn
Dec 31, 2018 827.70 Mn
Dec 31, 2015 650,000.00
Dec 31, 2014 1.21 Mn
Mar 31, 2014 178.17 Mn
Dec 31, 2013 1.75 Mn
Sep 30, 2013 24.12 Mn
API Access

Emergent BioSolutions Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=EBS&period=max&api_key=YOUR_API_KEY